Edition:
United Kingdom

Evogene Ltd (EVGN.OQ)

EVGN.OQ on NASDAQ Stock Exchange Global Market

3.91USD
19 Jan 2018
Change (% chg)

$0.06 (+1.56%)
Prev Close
$3.85
Open
$3.85
Day's High
$3.91
Day's Low
$3.84
Volume
1,200
Avg. Vol
6,911
52-wk High
$5.76
52-wk Low
$2.66

Chart for

About

Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 9.16 16.58
EPS (TTM): -- -- --
ROI: -- 8.30 10.60
ROE: -- 8.71 14.19

BRIEF-Evogene Announces Positive 2nd Year Field Trial Results In Corn Bio-Stimulant Ag-Biologicals Program

* EVOGENE ANNOUNCES POSITIVE 2ND YEAR FIELD TRIAL RESULTS IN CORN BIO-STIMULANT AG-BIOLOGICALS PROGRAM Source text for Eikon: Further company coverage:

10 Jan 2018

BRIEF-Evogene Q3 loss per share $0.20

* Evogene Ltd - ‍in 2018, Evogene expects net cash usage of $14 million to $16 million

22 Nov 2017

BRIEF-Evogene posts Q2 ‍loss per share $0.18​

* ‍Total revenues for Q2 of 2017 were $1.2 million, compared to $1.8 million for Q2 in 2016​

10 Aug 2017

BRIEF-Evogene ltd - entered into a multiyear collaboration with DuPont Pioneer

* Evogene Ltd - entered into a multiyear collaboration with DuPont Pioneer

26 Jul 2017

Earnings vs. Estimates